Overview

Oral and Intravenous Tranexamic Acid in Lumbar Spine Surgery

Status:
COMPLETED
Trial end date:
2018-07-16
Target enrollment:
Participant gender:
Summary
The purpose of this project is to compare the effectiveness of two different but well accepted routes of administration of tranexamic acid in order to reduce blood loss and need for transfusion in patients undergoing lumbar spine surgery. Specifically, this study seeks to identify if intravenous tranexamic acid is superior to oral tranexamic acid in reducing blood loss and need for transfusion.
Phase:
PHASE4
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Tranexamic Acid